Affordable Access

deepdyve-link
Publisher Website

Vitamin C increases the apoptosis via up-regulation p53 during cisplatin treatment in human colon cancer cells.

Authors
  • An, Sung Ho1
  • Kang, Jung Hoon
  • Kim, Dong Heui
  • Lee, Myeong Seon
  • 1 Genetic Engineering, Cheongju University, Korea. , (North Korea)
Type
Published Article
Journal
BMB reports
Publication Date
Mar 01, 2011
Volume
44
Issue
3
Pages
211–216
Identifiers
DOI: 10.5483/BMBRep.2011.44.3.211
PMID: 21429301
Source
Medline
License
Unknown

Abstract

Vitamin C (VC) is an important antioxidant and enzyme co-factor that works by stimulating the immune system and protecting against infections. It is well known that melanoma cells are more susceptible to VC than any other tumor cells. However, the role of VC in the treatment of colon cancer has not been studied. Cisplatin (CDDP) is a DNA damaging agent and is widely used for treating cancer, while the role of p53 in CDDP-induced cell death has been stressed. Using cell growth assays, morphological methods, Western blotting, flow cytometry, and DNA fragmentation analysis, we measured the expression of p53 level involved in the effect of VC on CDDP-induced apoptosis of HCT116, a human colon cancer cell line. CDDP plus VC treatment resulted in significantly increased apoptosis along with upregulation of p53 compared to untreated cells and/or CDDP-treated cells. These results suggest that VC enhanced CDDP sensitivity and apoptosis via upregulation of p53.

Report this publication

Statistics

Seen <100 times